Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. a case-control study

Transplantation

Volumn 89, Issue 10, 2010, Pages 1224-1230

  Joly, Pascal ^a   Bastuji Garin, Sylvie ^b   Frances, Camille ^c   Lebbe, Celeste ^b   Aubin, François ^d   Penso Assathiany, Dominique ^e   D'Incan, Michel ^f   Avril, Marie Françoise ^g   Lair, Guillaume ^a   Barete, Stéphane ^c   Euvrard, Sylvie ^h  

^a UNIVERSITÉ DE ROUEN   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Organ transplant; Squamous cell carcinoma; Warts

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY CD3; PREDNISOLONE;

ACTINIC KERATOSIS; ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLAT WART; GRAFT REJECTION; HEART GRAFT; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAPILLOMA; PRIORITY JOURNAL; RISK FACTOR; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VERRUCA VULGARIS; VERRUCOUS PAPILLOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TIME FACTORS; WARTS;

EID: 77952835699     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d7598b     Document Type: Article

References (31)

1. Hartevelt MM, Bouwes Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506.
2. Bouwes Bavinck JN, De Boer A, Vermeer BJ, et al. Sunlight keratotic skin lesions and skin cancer inrenal transplant recipients.Br J Dermatol 1993; 129: 242.
3. Naldi L, Fortina AB, Lovati S, et al. Risk ofnonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479.
4. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation.BrJDermatol2000; 143: 513.
5. Jensen P, Moller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatolol 2000; 42: 307.
6. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221.
7. Moloney FJ, ComberH,O'LorcainP,etal.Apopulation-based study of skin cancer incidence and prevalence in renal transplant recipients.Br J Dermatol 2006; 154: 498.
8. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
9. Boyle J, MacKie RM, Briggs JD, et al. Cancer, warts and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 702.
10. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715.
11. Ramsay HM, Fryer AA, Reece S, et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167.
12. Vallejo GH, Romero CJ, De Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005; 56: 87.
13. Shuttleworth D, Marks R, Griffin PJ, et al. Dysplastic epidermal change in immunosuppressed patients with renal transplants. Q J Med 1987; 64: 609.
14. Blohme I, Larko O. Skin lesionsinrenal transplant patients after10-23 years of immunosuppressive therapy. Acta Derm Venereol 1990; 70: 491.
15. Bouwes Bavinck JN, Feltkamp MC. Milk of human kindness? Hamlet, human papillomavirus, and warts. N Engl J Med 2004; 350: 2639.
16. De Jong-Tieben LM, Berkhout RJ, Smits HL, et al. High frequency of detection of epidermoldysplasia verruciformis-associated human pap-illomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367.
17. Feltkamp MC, Broer R, Di Summa FM, et al. Seroreactivity to epider-modysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695.
18. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389.
19. Masini C, Fuchs PG, Gabrielli F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003; 139: 890.
20. Berkhout RJ, Bouwes Bavinck JN, Ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087.
21. De Jong-Tieben LM, Berkhout RJ, Ter Schegget J, et al. The prevalence of human papillomavirus DNA inbenign keratotic skin lesions of renal transplant recipients with and withoutahistoryofskin cancerisequally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44.
22. Harwood CA, Surentheran T, McGregor JM, et al. Human papilloma-virus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289.
23. Pfister H, Fuchs PG, Majewksi S, et al. High prevalence of epider-modysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 20003; 295: 273.
24. Bouwes-Bavinck JN, EuvrardS,NaldiL, etal. Keratotic skin lesions and other risk factors are associated with skin cancer in organ transplant recipients: A case-control study in the Netherlands, United Kingdom, Germany, France and Italy. J Invest Dermatol 2007; 127: 1647.
25. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis and management. J Am Acad Dermatol 2002; 47: 1.
26. Richard MA, Grob JJ, Gouvernet J, et al. Role of sun exposure on benign melanocytic nevi. A first study in populations controlled for age, sex and phenotype. Ann Dermatol Venereol 1994; 121: 639.
27. De Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001; 19: 231.
28. Rosenquist K, Wennerberg J, Schildt EB, et al. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 991.
29. Jackson S, Harwood C, Thomas M, et al. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 protein. Genes Dev 2000; 14: 3063.
30. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: A highly sensitive and specific method for detection of human pap-illomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37: 3545.
31. Weissenborn SJ, Nindl I, Purdie K, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125: 93.